Modular Med (MODD) Enterprise Value to EBITDA Ratio

Public company logo of Modular Medical, Inc. (MODD)

Modular Medical (MODD) is currently transitioning to active sales of available MOD-1 pumps, focusing on FDA approval and pharmacy partnerships. The company's revenues are based on the sale of wearable devices for blood sugar monitoring for patients with diabetes. This daily price action reflecting the evolution of quotes confirms its status as a diabetes-tech innovator with a metric at 0.00, cementing the brand's leadership potential in the field of simplified electronics.

Modular Medical, Inc. - MODD Company Value to EBITDA (period 11/23/2025 - 11/10/2026)

Comprehensive metric breakdowns and analytics for modular-medical.com (MODD)

- current price and projected stock value:
Stock Price Modular Medical, Inc.|MODD - Analyst Median Target
- market capitalization details:
Market Valuation MODD|MODD - Full Business Value
- business book valuation details:
Book Value per Share Modular Medical|MODD - Total Stockholders' Equity|Market Capitalization to Book Value Ratio modular-medical.com|MODD - Total Business Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Modular Medical|MODD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Modular Medical, Inc.|MODD - Company Total Debt|Debts to Book Capitalization MODD|MODD - Long-Term Debt|Company Short-Term Debts Modular Medical|Quick Ratio modular-medical.com
- financial results and valuation multiples details:
MODD - Net Financial Result|Projected Future Earnings Modular Medical|MODD - Price to Earnings Ratio|Forward P/E Multiple Modular Medical, Inc.|MODD - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MODD|MODD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Modular Medical|MODD - Earnings per share for the trailing year|Quarterly EPS earnings growth modular-medical.com|MODD - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Modular Medical
Analysis of all company metrics:Modular Med MODD
Manufactured products of Modular Medical, Inc.

Market optimism regarding the leadership of Modular Medical (MODD) in diabetes tech requires verification through the actual scale of capital expenditures and debt load. By analyzing the enterprise value to EBITDA multiple, an investor assesses the total business value relative to its ability to generate cash flow, which allows for the determination of the asset's fair price considering the R&D intensity of insulin pump development.

Competitor analysis

EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|ReWalk Robotics Ltd. (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Autonomix Medical|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Company Value to EBITDA Bone Biologics Corp. BBLG|EV/EBITDA Multiple AXNX|Biolase Inc. - Enterprise Value to Operating Income Before Depreciation|Dynatronics - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization